Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don M Benson

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Blood|January 19, 2013
Can NKT cells extinguish smoldering myeloma?Don M Benson
Hematology. American Society of Hematology. Education Program|December 4, 2016
Checkpoint inhibition in myelomaDon M Benson
Cureus|December 2, 2024
Near-Fatal Aspiration of Drug ContrabandDon M Benson
Leukemia & Lymphoma|March 20, 2012
The role of natural killer cells in immunity against multiple myelomaJames Godfrey, Don M Benson
Leukemia & Lymphoma|July 7, 2007
Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemiaDon M Benson, Megan K Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
CS1-directed monoclonal antibody therapy for multiple myelomaDon M Benson, John C Byrd
Cancer Immunology Research|March 5, 2014
Killer immunoglobulin-like receptors and tumor immunityDon M Benson, Michael A Caligiuri
Blood Cancer Discovery|December 19, 2025
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk MyelomaDon M Benson, Michael A Caligiuri
Mayo Clinic Proceedings|May 12, 2007
Thalidomide-induced fulminant hepatic failureMehdi Hamadani, Don M Benson, Edward A Copelan
Expert Review of Endocrinology & Metabolism|February 16, 2019
Catecholamines can mediate stress-related effects on tumor progressionEric V Yang, Don M Benson, Ronald Glaser
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Blood|January 19, 2013
Can NKT cells extinguish smoldering myeloma?Don M Benson
Hematology. American Society of Hematology. Education Program|December 4, 2016
Checkpoint inhibition in myelomaDon M Benson
Cureus|December 2, 2024
Near-Fatal Aspiration of Drug ContrabandDon M Benson
Leukemia & Lymphoma|March 20, 2012
The role of natural killer cells in immunity against multiple myelomaJames Godfrey, Don M Benson
Leukemia & Lymphoma|July 7, 2007
Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemiaDon M Benson, Megan K Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
CS1-directed monoclonal antibody therapy for multiple myelomaDon M Benson, John C Byrd
Cancer Immunology Research|March 5, 2014
Killer immunoglobulin-like receptors and tumor immunityDon M Benson, Michael A Caligiuri
Blood Cancer Discovery|December 19, 2025
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk MyelomaDon M Benson, Michael A Caligiuri
Mayo Clinic Proceedings|May 12, 2007
Thalidomide-induced fulminant hepatic failureMehdi Hamadani, Don M Benson, Edward A Copelan
Expert Review of Endocrinology & Metabolism|February 16, 2019
Catecholamines can mediate stress-related effects on tumor progressionEric V Yang, Don M Benson, Ronald Glaser
Pageof 11